Positive and negative regulators of transforming growth factor beta 1/bone morphogenetic protein pathways are constitutively expressed in mesangial cells

Autor: Maciel, TT, Schor, N, Campos, AH

Publikováno v: Critical Care

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmc_________::f62e7269a0ec6a8417a731000572c8a0
http://europepmc.org/articles/PMC3301117

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Interactions between eosinophils and IL-5Rα-positive mast cells in nonadvanced systemic mastocytosis.

Autor: Lefèvre G; University of Lille, Institut National de la Santé et de la Recherche Médicale (INSERM), Centre Hospitalier Universitaire (CHU) Lille, and Institute for Translational Research in Inflammation (INFINITE), Lille, France; Institut d'Immunologie, CHU Lille, Lille, France; National Reference Center for Hypereosinophilic Syndromes (CEREO). Electronic address: guillaume.lefevre@chu-lille.fr., Gibier JB; University of Lille, Institut de Pathologie, Centre de Biopathologie, CHU Lille, Lille, France., Bongiovanni A; Centre National de la Recherche Scientifique (CNRS), INSERM, CHU Lille, University of Lille, Institut Pasteur de Lille, Lille, France., Lhermitte L; Laboratoire d'Onco-Hématologie, Hôpital Necker-Enfants Malades, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France; University of Paris, Institut Imagine, INSERM, Paris, France; French Reference Center for Mastocytosis (CEREMAST), Hôpital Necker-Enfants Malades, AP-HP, Paris, France., Rossignol J; University of Paris, Institut Imagine, INSERM, Paris, France; French Reference Center for Mastocytosis (CEREMAST), Hôpital Necker-Enfants Malades, AP-HP, Paris, France; Department of Hematology, Hôpital Necker-Enfants Malades, AP-HP, Paris, France., Anglo E; University of Lille, Institut National de la Santé et de la Recherche Médicale (INSERM), Centre Hospitalier Universitaire (CHU) Lille, and Institute for Translational Research in Inflammation (INFINITE), Lille, France; Institut d'Immunologie, CHU Lille, Lille, France., Dendooven A; University of Lille, Institut National de la Santé et de la Recherche Médicale (INSERM), Centre Hospitalier Universitaire (CHU) Lille, and Institute for Translational Research in Inflammation (INFINITE), Lille, France; Institut d'Immunologie, CHU Lille, Lille, France., Dubois R; University of Lille, Institut de Pathologie, Centre de Biopathologie, CHU Lille, Lille, France., Terriou L; University of Lille, Institut National de la Santé et de la Recherche Médicale (INSERM), Centre Hospitalier Universitaire (CHU) Lille, and Institute for Translational Research in Inflammation (INFINITE), Lille, France; National Reference Center for Hypereosinophilic Syndromes (CEREO); Département de Médecine Interne et Immunologie Clinique, CHU Lille, Lille, France., Launay D; University of Lille, Institut National de la Santé et de la Recherche Médicale (INSERM), Centre Hospitalier Universitaire (CHU) Lille, and Institute for Translational Research in Inflammation (INFINITE), Lille, France; National Reference Center for Hypereosinophilic Syndromes (CEREO); Département de Médecine Interne et Immunologie Clinique, CHU Lille, Lille, France., Barete S; CEREMAST, AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Unit de Dermatologie, Sorbonne Université Paris, Paris, France., Esnault S; University of Lille, Institut National de la Santé et de la Recherche Médicale (INSERM), Centre Hospitalier Universitaire (CHU) Lille, and Institute for Translational Research in Inflammation (INFINITE), Lille, France; Institut d'Immunologie, CHU Lille, Lille, France; Department of Medicine, Division of Allergy, Pulmonary, and Critical Care Medicine, University of Wisconsin-Madison School of Medicine and Public Health, Madison, Wis., Frenzel L; University of Paris, Institut Imagine, INSERM, Paris, France; French Reference Center for Mastocytosis (CEREMAST), Hôpital Necker-Enfants Malades, AP-HP, Paris, France; Department of Hematology, Hôpital Necker-Enfants Malades, AP-HP, Paris, France., Gourguechon C; Department of Hematology, CHU Amiens, Amiens, France., Ballul T; University of Paris, Institut Imagine, INSERM, Paris, France; French Reference Center for Mastocytosis (CEREMAST), Hôpital Necker-Enfants Malades, AP-HP, Paris, France; Department of Hematology, Hôpital Necker-Enfants Malades, AP-HP, Paris, France., Dezoteux F; University of Lille, Institut National de la Santé et de la Recherche Médicale (INSERM), Centre Hospitalier Universitaire (CHU) Lille, and Institute for Translational Research in Inflammation (INFINITE), Lille, France; National Reference Center for Hypereosinophilic Syndromes (CEREO); Department of Dermatology, CHU Lille, Lille, France., Staumont-Salle D; University of Lille, Institut National de la Santé et de la Recherche Médicale (INSERM), Centre Hospitalier Universitaire (CHU) Lille, and Institute for Translational Research in Inflammation (INFINITE), Lille, France; National Reference Center for Hypereosinophilic Syndromes (CEREO); Department of Dermatology, CHU Lille, Lille, France., Copin MC; Department of Pathology, CHU Angers, University of Angers, INSERM, CNRS, CRCI(2)NA, Angers, France., Rignault-Bricard R; University of Paris, Institut Imagine, INSERM, Paris, France., Maciel TT; University of Paris, Institut Imagine, INSERM, Paris, France., Damaj G; Institut d'Hématologie, University of Caen Normandie, Caen, France., Tardivel M; Centre National de la Recherche Scientifique (CNRS), INSERM, CHU Lille, University of Lille, Institut Pasteur de Lille, Lille, France., Crinquette-Verhasselt M; University of Lille, Institut de Pathologie, Centre de Biopathologie, CHU Lille, Lille, France., Dubreuil P; Signaling, Hematopoiesis, and Mechanism of Oncogenesis (CRCM), CEREMAST, and Association Française pour les Initiatives de Recherche sur le Mastocyte et les Mastocytose (AFIRMM) studies, INSERM U1068; Institut Paoli-Calmettes; UM105, Aix-Marseille University; and CNRS, UMR7258, Marseille, France., Maouche-Chrétien L; University of Paris, Institut Imagine, INSERM, Paris, France., Bruneau J; University of Paris, Institut Imagine, INSERM, Paris, France; French Reference Center for Mastocytosis (CEREMAST), Hôpital Necker-Enfants Malades, AP-HP, Paris, France; Department of Pathology, Hôpital Necker-Enfants Malades, AP-HP, Paris, France., Lortholary O; University of Paris, Institut Imagine, INSERM, Paris, France; French Reference Center for Mastocytosis (CEREMAST), Hôpital Necker-Enfants Malades, AP-HP, Paris, France., Duployez N; CNRS, INSERM, CHU Lille, Cancer Heterogeneity, Plasticity, and Resistance to Therapies (CANTHER), University of Lille, Institut d'Hématologie, CHU Lille, Lille, France., Behal H; University of Lille, CHU Lille, Evaluation des Technologies de Santé et des Pratiques Médicales (METRICS), Lille, France., Molina TJ; University of Paris, Institut Imagine, INSERM, Paris, France; Signaling, Hematopoiesis, and Mechanism of Oncogenesis (CRCM), CEREMAST, and Association Française pour les Initiatives de Recherche sur le Mastocyte et les Mastocytose (AFIRMM) studies, INSERM U1068; Institut Paoli-Calmettes; UM105, Aix-Marseille University; and CNRS, UMR7258, Marseille, France., Hermine O; University of Paris, Institut Imagine, INSERM, Paris, France; French Reference Center for Mastocytosis (CEREMAST), Hôpital Necker-Enfants Malades, AP-HP, Paris, France; Department of Hematology, Hôpital Necker-Enfants Malades, AP-HP, Paris, France. Electronic address: olivier.hermine@aphp.fr.

Publikováno v: The Journal of allergy and clinical immunology [J Allergy Clin Immunol] 2024 Aug 14. Date of Electronic Publication: 2024 Aug 14.

Oral famotidine reduces the plasma level of soluble P-selectin in children with sickle cell disease.

Autor: Allali S; Department of General Paediatrics and Paediatric Infectious Diseases, Sickle Cell Centre, Assistance Publique - Hôpitaux de Paris (AP-HP), Necker-Enfants Malades Hospital, Université Paris Cité, Paris, France.; Laboratory of Cellular and Molecular Mechanisms of Haematological Disorders and Therapeutical Implications, Imagine Institute, Inserm U1163, Université Paris Cité, Paris, France.; Laboratory of Excellence GR-Ex, Paris, France., Marquant F; Unité de Recherche Clinique/Centre d'investigation Clinique, Necker-Enfants Malades Hospital, AP-HP, Paris, France., Rignault-Bricard R; Laboratory of Cellular and Molecular Mechanisms of Haematological Disorders and Therapeutical Implications, Imagine Institute, Inserm U1163, Université Paris Cité, Paris, France., Taylor M; Department of General Paediatrics and Paediatric Infectious Diseases, Sickle Cell Centre, Assistance Publique - Hôpitaux de Paris (AP-HP), Necker-Enfants Malades Hospital, Université Paris Cité, Paris, France.; Laboratory of Excellence GR-Ex, Paris, France., Brice J; Department of General Paediatrics and Paediatric Infectious Diseases, Sickle Cell Centre, Assistance Publique - Hôpitaux de Paris (AP-HP), Necker-Enfants Malades Hospital, Université Paris Cité, Paris, France.; Laboratory of Excellence GR-Ex, Paris, France., de Montalembert M; Department of General Paediatrics and Paediatric Infectious Diseases, Sickle Cell Centre, Assistance Publique - Hôpitaux de Paris (AP-HP), Necker-Enfants Malades Hospital, Université Paris Cité, Paris, France.; Laboratory of Excellence GR-Ex, Paris, France., Maciel TT; Laboratory of Cellular and Molecular Mechanisms of Haematological Disorders and Therapeutical Implications, Imagine Institute, Inserm U1163, Université Paris Cité, Paris, France.; Laboratory of Excellence GR-Ex, Paris, France., Elie C; Unité de Recherche Clinique/Centre d'investigation Clinique, Necker-Enfants Malades Hospital, AP-HP, Paris, France., Hermine O; Laboratory of Cellular and Molecular Mechanisms of Haematological Disorders and Therapeutical Implications, Imagine Institute, Inserm U1163, Université Paris Cité, Paris, France.; Laboratory of Excellence GR-Ex, Paris, France.; Department of Haematology, Necker-Enfants Malades Hospital, AP-HP, Université Paris Cité, Paris, France.; Reference Centre for Mastocytosis, Necker-Enfants Malades Hospital, AP-HP, Université Paris Cité, Paris, France.

Publikováno v: British journal of haematology [Br J Haematol] 2024 Jan; Vol. 204 (1), pp. 346-351. Date of Electronic Publication: 2023 Sep 18.